Tranexamic acid for sudden brain bleeding after stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have a spontaneous brain bleed (not from trauma) diagnosed within 4.5 hours of stroke symptom start
- The bleed is not caused by blood thinners, clot-busting drugs, or an abnormal blood vessel/tumor
- You are not pregnant, breastfeeding, or able to become pregnant (or this is handled according to the study rules)
- Your brain bleed size is not larger than 60 mL (based on an imaging measurement)
- You can be followed for 90 days and you are not joining another study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.
This Phase 3 study tests whether tranexamic acid (a medicine that helps blood clot) can stop a chronic subdural hematoma from getting worse. It’s for people diagnosed by CT who are being treated without surgery at first.
This trial tests whether a medicine called tranexamic acid (which helps blood clot) can help your body reabsorb a subdural hematoma, a type of bleeding on the brain, without needing surgery. If successful, this treatment could reduce the need for surgery and improve recovery.
Hear when a new Intracerebral Hemorrhagic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.